These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2490824)

  • 1. Hypertension as a risk factor for renal disease. Review of clinical and epidemiological evidence.
    Whelton PK; Klag MJ
    Hypertension; 1989 May; 13(5 Suppl):I19-27. PubMed ID: 2490824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and prevention of blood pressure-related renal disease.
    Whelton PK; Perneger TV; Brancati FL; Klag MJ
    J Hypertens Suppl; 1992 Dec; 10(7):S77-84. PubMed ID: 1291660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension and endstage renal disease.
    Brown TE; Carter BL
    Ann Pharmacother; 1994 Mar; 28(3):359-66. PubMed ID: 8193427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertensive emergencies.
    Moore MA
    Am Fam Physician; 1980 Mar; 21(3):141-6. PubMed ID: 7355684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A call to action for more aggressive treatment of hypertension.
    Lenfant C; Roccella EJ
    J Hypertens Suppl; 1999 Feb; 17(1):S3-7. PubMed ID: 10340837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2017 May; 35(5):922-944. PubMed ID: 28141660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. End-stage renal disease: why aren't improvements in hypertension treatment reducing the risk?
    Jaimes E; Galceran JM; Raij L
    Curr Opin Cardiol; 1996 Sep; 11(5):471-6. PubMed ID: 8889372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension as a risk factor for progression of chronic renal disease.
    Epstein M
    Blood Press Suppl; 1994; 1():23-8. PubMed ID: 8205294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating multiple-risk hypertensive populations.
    Oparil S
    Am J Hypertens; 1999 Nov; 12(11 Pt 2):121S-129S. PubMed ID: 10596763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension and renal dysfunction: NHANES III.
    Jones CA
    J Am Soc Nephrol; 2003 Jul; 14(7 Suppl 2):S71-5. PubMed ID: 12819306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Muntner P; Davis BR; Cushman WC; Bangalore S; Calhoun DA; Pressel SL; Black HR; Kostis JB; Probstfield JL; Whelton PK; Rahman M;
    Hypertension; 2014 Nov; 64(5):1012-21. PubMed ID: 25259745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in the incidence of end-stage renal failure due to hypertension and vascular disease in Australia, 1972-1991.
    Stewart JH; Disney AP; Mathew TH
    Aust N Z J Med; 1994 Dec; 24(6):696-700. PubMed ID: 7717922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does treated primary hypertension lead to end-stage renal disease? A 20-year follow-up of the Primary Prevention Study in Göteborg, Sweden.
    Siewert-Delle A; Ljungman S; Andersson OK; Wilhelmsen L
    Nephrol Dial Transplant; 1998 Dec; 13(12):3084-90. PubMed ID: 9870470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.
    Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S
    Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group.
    Shulman NB; Ford CE; Hall WD; Blaufox MD; Simon D; Langford HG; Schneider KA
    Hypertension; 1989 May; 13(5 Suppl):I80-93. PubMed ID: 2490833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive Hemodialysis, Blood Pressure, and Antihypertensive Medication Use.
    Bakris GL; Burkart JM; Weinhandl ED; McCullough PA; Kraus MA
    Am J Kidney Dis; 2016 Nov; 68(5S1):S15-S23. PubMed ID: 27772639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National High Blood Pressure Education Program Working Group report on hypertension and chronic renal failure.
    Arch Intern Med; 1991 Jul; 151(7):1280-7. PubMed ID: 2064478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of losartan on the lifetime incidence of ESRD and costs in Mexico.
    Arredondo A; Burke TA; Carides GW; Lemus E; Querol J
    Rev Invest Clin; 2005; 57(3):399-405. PubMed ID: 16187699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The intervention trial in the evaluation of antihypertensive therapy].
    Mancia G; Cattaneo BM; Grassi G
    Ann Ital Med Int; 1995 Oct; 10 Suppl():108S-111S. PubMed ID: 8562256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.